Connect Biopharma is trading 5.27% higher at $0.81 in pre-market on November 4, 2026, alongside a broader biotech lift; no company-specific announcement explaining the move has surfaced. - XBI is up 2.08% pre-market. - The company’s investor-relations page lists August 12 as its latest financial-results release. - The next estimated earnings date is November 11, so the move does not appear to reflect an earnings release today.